{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:44:54Z","timestamp":1790210694352,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.micpath.2022.105855","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T03:36:37Z","timestamp":1666928197000},"page":"105855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"PA","title":["Promising targets for immunotherapeutic approaches against Acinetobacter baumannii"],"prefix":"10.1016","volume":"173","author":[{"given":"Stella","family":"Buchhorn de Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-0832","authenticated-orcid":false,"given":"Daiane Drawanz","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/CMR.9.2.148","article-title":"Acinetobacter ssp. as nosocomial Pathogens","volume":"9","author":"Bergogne-B\u00e9","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.micpath.2022.105855_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.ASW.0000363527.08501.a3","article-title":"Insights into Acinetobacter war-wound infections, biofilms, and control","volume":"23","author":"Dallo","year":"2010","journal-title":"Adv. Skin Wound Care"},{"issue":"6","key":"10.1016\/j.micpath.2022.105855_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1371\/journal.pone.0100727","article-title":"Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2022.105855_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.micpath.2016.06.032","article-title":"In vivo validation of the immunogenicity of recombinant Baumannii Acinetobactin Utilization A protein (rBauA)","volume":"98","author":"Esmaeilkhani","year":"2016","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/viru.2.2.15061","article-title":"Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections","volume":"2","author":"Mihu","year":"2011","journal-title":"Virulence"},{"issue":"12","key":"10.1016\/j.micpath.2022.105855_bib6","doi-asserted-by":"crossref","first-page":"e00591","DOI":"10.1128\/IAI.00591-17","article-title":"The capsular polysaccharide of Acinetobacter baumannii is an obstacle for therapeutic passive immunization strategies","volume":"85","author":"Wang-Lin","year":"2017","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/IAI.05653-11","article-title":"Poly-n-acetyl-\u03b2-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections","volume":"80","author":"Bentancor","year":"2012","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.micpath.2022.105855_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1128\/IAI.01184-12","article-title":"The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization","volume":"81","author":"Russo","year":"2013","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijmm.2015.10.005","article-title":"Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease","volume":"306","author":"Garg","year":"2016","journal-title":"NucAb. Int. J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2022.105855_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fmicb.2016.00158","article-title":"Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate","volume":"7","author":"Singh","year":"2016","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105855_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/2049-632X.12125","article-title":"Acinetobacter baumannii: evolution of a global pathogen","volume":"71","author":"Antunes","year":"2014","journal-title":"Pathog. Dis."},{"issue":"6","key":"10.1016\/j.micpath.2022.105855_bib12","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1111\/jam.15130","article-title":"Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review","volume":"131","author":"Nguyen","year":"2021","journal-title":"J. Appl. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","article-title":"Uncovering the mechanisms of Acinetobacter baumannii virulence","volume":"16","author":"Harding","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"issue":"10","key":"10.1016\/j.micpath.2022.105855_bib14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2174\/1389201014666131226123511","article-title":"First steps towards a vaccine against Acinetobacter baumannii","volume":"14","author":"Garcia-Quintanilla","year":"2014","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.micpath.2022.105855_bib15","first-page":"1","article-title":"Antimicrobial peptide Cec4 eradicates the bacteria of clinical carbapenem-resistant Acinetobacter baumannii biofilm","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2010.10.052","article-title":"Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine","volume":"29","author":"McConnell","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2022.105855_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fimmu.2020.00076","article-title":"Monoclonal IgM antibodies targeting Candida albicans Hyr1 provide cross-kingdom protection against Gram-negative bacteria","volume":"11","author":"Youssef","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.micpath.2022.105855_bib18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3201\/eid0808.020014","article-title":"Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, taiwan","volume":"8","author":"Hsueh","year":"2002","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/jhin.2002.1348","article-title":"Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit","volume":"53","author":"Wang","year":"2003","journal-title":"J. Hosp. Infect."},{"issue":"4","key":"10.1016\/j.micpath.2022.105855_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/antibiotics9040178","article-title":"Pan-drug resistant Acinetobacter baumannii, but not other strains, are resistant to the bee venom peptide mellitin","volume":"9","author":"Rangel","year":"2020","journal-title":"Antibiotics"},{"issue":"26","key":"10.1016\/j.micpath.2022.105855_bib21","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/j.vaccine.2017.05.017","article-title":"Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection","volume":"35","author":"Ainsworth","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.micpath.2022.105855_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pathogens10030373","article-title":"Acinetobacter baumannii antibiotic resistance mechanisms","volume":"10","author":"Kyriakidis","year":"2021","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1574-6976.2012.00344.x","article-title":"Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models","volume":"37","author":"McConnell","year":"2013","journal-title":"FEMS Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.micpath.2014.07.007","article-title":"The role of filamentous hemagglutinin adhesin in adherence and biofilm formation in Acinetobacter baumannii ATCC19606T","volume":"74","author":"Astaneh","year":"2014","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2022.105855_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"36","key":"10.1016\/j.micpath.2022.105855_bib26","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1016\/j.vaccine.2015.07.031","article-title":"OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections","volume":"33","author":"Huang","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.vaccine.2014.02.083","article-title":"Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice","volume":"33","author":"KuoLee","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib28","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3892\/mmr.2017.6688","article-title":"Small protein A and phospholipase D immunization serves a protective role in a mouse pneumonia model of Acinetobacter baumannii infection","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.micpath.2022.105855_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.01379","article-title":"Anti-outer membrane vesicle antibodies increase antibiotic sensitivity of pan-drug-resistant Acinetobacter baumannii","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/j.micpath.2022.105855_bib30","first-page":"2677","article-title":"Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock","volume":"35","author":"Kreymann","year":"2007","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib31","first-page":"e01110","article-title":"New treatment options against carbapenem-resistant Acinetobacter baumannii infections","volume":"63","author":"Isler","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2022.105855_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112107","article-title":"Recent advances in management of COVID-19: a review","volume":"143","author":"Mouffak","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.AID-0026-2014","article-title":"History and practice: antibodies in infectious diseases","volume":"3","author":"Hey","year":"2015","journal-title":"Microbiol. Spectr."},{"issue":"7","key":"10.1016\/j.micpath.2022.105855_bib34","first-page":"663","article-title":"The use of antibodies in the treatment of infectious diseases","volume":"50","author":"Chan","year":"2009","journal-title":"Singap. Med. J."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.abb.2012.02.011","article-title":"Mechanism of action of therapeutic monoclonal antibodies: promises and pitfalls of in vitro and in vivo assays","volume":"526","author":"Golay","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2014.06.010","article-title":"How antibodies use complement to regulate antibody responses","volume":"61","author":"S\u00f6rman","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.micpath.2022.105855_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.942482","article-title":"CipA mediates complement resistance of Acinetobacter baumannii by formation of a Factor I-dependent quadripartite assemblage","volume":"13","author":"Ries","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.micpath.2022.105855_bib38","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/brain\/awz222","article-title":"Targeting the complement system in bacterial meningitis","volume":"142","author":"Koelman","year":"2019","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.micpath.2022.105855_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.copbio.2008.10.002","article-title":"Antibodies for the treatment of bacterial infections: current experience and future prospects","volume":"19","author":"Bebbington","year":"2008","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.micpath.2022.105855_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-8-216","article-title":"Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells","volume":"8","author":"Choi","year":"2008","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2022.105855_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105112","article-title":"A hypothetical adhesin protein induces anti-biofilm antibodies against multi-drug resistant Acinetobacter baumannii","volume":"159","author":"de Freitas","year":"2021","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1574-6968.2009.01820.x","article-title":"Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins","volume":"301","author":"Kim","year":"2009","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.micpath.2022.105855_bib43","first-page":"1","article-title":"Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1009291","article-title":"Capsule carbohydrate structure determines virulence in Acinetobacter baumannii","volume":"17","author":"Talyansky","year":"2021","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029446","article-title":"Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.micpath.2022.105855_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3201\/eid0203.960306","article-title":"Antibody-based therapies for emerging infectious diseases","volume":"2","author":"Casadevall","year":"1996","journal-title":"Emerg. Infect. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2022.105855_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.00162-21","article-title":"Monoclonal antibody therapy against Acinetobacter baumannii","volume":"89","author":"Nielsen","year":"2021","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.micpath.2022.105855_bib48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.118.253617","article-title":"Antibody dependent enhancement of Acinetobacter baumannii infection in a mouse pneumonia model","volume":"368","author":"Wang-Lin","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.micpath.2022.105855_bib49","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ilar.46.3.258","article-title":"Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources","volume":"46","author":"Lipman","year":"2005","journal-title":"ILAR J."},{"key":"10.1016\/j.micpath.2022.105855_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-61779-931-0_7","article-title":"Hybridoma technology for the generation of monoclonal antibodies","volume":"901","author":"Zhang","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.micpath.2022.105855_bib51","first-page":"1","article-title":"Phage Display derived monoclonal antibodies: from bench to bedside","volume":"89","author":"Alfaleh","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2022.105855_bib52","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.cell.2021.02.035","article-title":"Extremely potent human monoclonal antibodies from COVID-19 convalescent patients","volume":"184","author":"Andreano","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.micpath.2022.105855_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics9040155","article-title":"Monoclonal antibodies as an antibacterial approach against bacterial pathogens","volume":"9","author":"Zurawski","year":"2020","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.micpath.2022.105855_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jin2.48","article-title":"Nanodelivery strategies for the treatment of multidrug-resistant bacterial infections","volume":"3","author":"Jiang","year":"2018","journal-title":"J. Interdisc. Nanomed."},{"issue":"4","key":"10.1016\/j.micpath.2022.105855_bib55","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/infdis\/jix315","article-title":"Monoclonal antibody protects against Acinetobacter baumannii infection by enhancing bacterial clearance and evading sepsis","volume":"216","author":"Nielsen","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105855_bib56","article-title":"Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model","volume":"161","author":"Erami","year":"2021","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib57","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jam.14135","article-title":"Specific egg yolk antibodies (IgY) confer protection against acinetobacter baumannii in a murine pneumonia model","volume":"126","author":"Jahangiri","year":"2019","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-81356-8","article-title":"Specific Egg Yolk Immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter Baumannii pneumonia infection","volume":"11","author":"Jahangiri","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-16894-w","article-title":"Specific egg yolk antibody raised to biofilm associated protein (Bap) is protective against murine pneumonia caused by acinetobacter baumannii","volume":"12","author":"Ranjbar","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib60","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/ijms18020458","article-title":"Antibiotic resistance determinant-focused Acinetobacter baumannii vaccine designed using reverse vaccinology","volume":"18","author":"Ni","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2022.105855_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104114","article-title":"New putative vaccine candidates against Acinetobacter baumannii using the reverse vaccinology method","volume":"143","author":"Fereshteh","year":"2020","journal-title":"Microb. Pathog."},{"issue":"7","key":"10.1016\/j.micpath.2022.105855_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0068940","article-title":"Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance","volume":"8","author":"Joice","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2016.04.019","article-title":"Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii","volume":"96","author":"Zhang","year":"2016","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-12789-3","article-title":"Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii","volume":"7","author":"Singh","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2022.105855_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.micpath.2019.03.031","article-title":"Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii","volume":"131","author":"Bolourchi","year":"2019","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib66","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12866-019-1615-3","article-title":"Blp1 protein shows virulence-associated features and elicits protective immunity to Acinetobacter baumannii infection","volume":"19","author":"Skerni\u0161kyt\u0117","year":"2019","journal-title":"BMC Microbiol."},{"issue":"35","key":"10.1016\/j.micpath.2022.105855_bib67","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1016\/j.vaccine.2018.07.040","article-title":"Polysaccharides as vaccine adjuvants","volume":"36","author":"Sun","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2022.105855_bib68","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3390\/pharmaceutics14071357","article-title":"Safety and prophylactic efficacy of liposome-based vaccine against the drug-resistant Acinetobacter Baumannii in mice","volume":"14","author":"Khan","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.micpath.2022.105855_bib69","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1128\/AAC.49.4.1432-1440.2005","article-title":"Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of \u03b2-barrel outer membrane proteins","volume":"49","author":"Mussi","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.micpath.2022.105855_bib70","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s10989-020-10056-0","article-title":"Outer membrane protein, Oma87 prevents Acinetobacter baumannii infection","volume":"26","author":"Rasooli","year":"2020","journal-title":"Int. J. Pept. Res. Therapeut."},{"issue":"5","key":"10.1016\/j.micpath.2022.105855_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007056","article-title":"The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection","volume":"14","author":"Uppuluri","year":"2018","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pep.2010.11.019","article-title":"Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies","volume":"77","author":"McConnell","year":"2011","journal-title":"Protein Expr. Purif."},{"issue":"2","key":"10.1016\/j.micpath.2022.105855_bib73","first-page":"180","article-title":"Immunogenicity of cork and loop domains of recombinant baumannii acinetobactin utilization protein in murine model","volume":"11","author":"Esmaeilkhani","year":"2019","journal-title":"Avicenna J. Med. Biotechnol. (AJMB)"},{"key":"10.1016\/j.micpath.2022.105855_bib74","first-page":"578","article-title":"Iron regulated outer membrane proteins (IROMPs) as potential targets against carbapenem-resistant Acinetobacter spp. isolated from a Medical Centre in Malaysia","volume":"131","author":"Hwa","year":"2010","journal-title":"Indian J. Med. Res."},{"issue":"16","key":"10.1016\/j.micpath.2022.105855_bib75","first-page":"1","article-title":"Monoclonal antibodies against the iron regulated outer membrane proteins of acinetobacter baumannii are bactericidal","volume":"1","author":"Goel","year":"2001","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2022.105855_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.933445","article-title":"Hybrid antigens expressing surface loops of BauA from Acinetobacter baumannii are capable of inducing protection against infection","volume":"13","author":"Chaudhuri","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2022.105855_bib77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fcimb.2020.00253","article-title":"Insights into mechanisms of biofilm formation in Acinetobacter baumannii and implications for uropathogenesis","volume":"10","author":"Colquhoun","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2022.105855_bib78","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1099\/jmm.0.000058","article-title":"Molecular detection of genes related to biofilm formation in multidrug-resistant Acinetobacter baumannii isolated from clinical settings","volume":"64","author":"Badmasti","year":"2015","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105855_bib79","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/antibiotics9030119","article-title":"Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen","volume":"9","author":"Moubareck","year":"2020","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.micpath.2022.105855_bib80","first-page":"93","article-title":"Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein","volume":"12","author":"Sun","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"10","key":"10.1016\/j.micpath.2022.105855_bib81","doi-asserted-by":"crossref","first-page":"e00904","DOI":"10.1128\/AAC.00904-17","article-title":"A human biofilm-disrupting monoclonal antibody potentiates antibiotic efficacy in rodent models of both Staphylococcus aureus and Acinetobacter baumannii infections","volume":"61","author":"Xiong","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.micpath.2022.105855_bib82","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1128\/IAI.01464-08","article-title":"Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein","volume":"77","author":"Shahrooei","year":"2009","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.micpath.2022.105855_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020918","article-title":"Monoclonal antibodies against accumulation-associated protein affect EPS biosynthesis and enhance bacterial accumulation of Staphylococcus epidermidis","volume":"6","author":"Hu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2022.105855_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4414\/smw.2019.20052","article-title":"Design and evaluation of a Multi-Epitope assembly peptide vaccine against Acinetobacter baumannii infection in mice","volume":"149","author":"Ren","year":"2019","journal-title":"Swiss Med. Wkly."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022004685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022004685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:47:13Z","timestamp":1760111233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401022004685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":84,"alternative-id":["S0882401022004685"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105855","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising targets for immunotherapeutic approaches against Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105855"}}